Colleen Kraft, MD
Infectious Disease · Atlanta, GANPI 1083650048
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $102,890 of the $103,033 with a category attached, or 99.9%. Rebiotix Inc. accounts for 67.0% of it on its own, with 5 other manufacturers making up the rest. Among infectious disease clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 36 payments — averaging $2862.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Rebiotix Inc.$69K
- Ferring Microbiome Inc.$30K
- Ferring Pharmaceuticals Inc.$2K
- Roche Diagnostics Corporation$1K
- Opgen, Inc.$500
- Sanofi Pasteur Inc.$143
Across 6 payments — averaging $2168.02 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ferring Pharmaceuticals AS$13K
What the payments were for
- Consulting fees$102,890100%
- Food & beverage$1430%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Rebiotix Inc. | 22 | $69,000 |
| Ferring Microbiome Inc. | 10 | $30,000 |
| Ferring Pharmaceuticals Inc. | 1 | $2,390 |
| Roche Diagnostics Corporation | 1 | $1,000 |
| Opgen, Inc. | 1 | $500 |
| Sanofi Pasteur Inc. | 1 | $143 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REBYOTA$99,000
- CD cobas Analyzer Series$1,000
- BEYFORTUS$143
How this compares
$103,033 in reported general payments places this provider in the 95th percentile of 260 infectious disease providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other infectious disease in Atlanta
- Zandraetta Tims-CookAtlanta$848K
- Larry AndersonAtlanta$300K
- Quintin RobinsonAtlanta$270K
- James McMillenAtlanta$177K
- Leandro MenaAtlanta$141K
- Walter OrensteinAtlanta$78K
- Nadine RouphaelAtlanta$66K
- Kimberly WorkowskiAtlanta$53K
- Bernard BransonAtlanta$36K
- Michelle JonesAtlanta$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.